Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN
Journal
The journal of allergy and clinical immunology. In practice
Journal Volume
11
Journal Issue
10
Date Issued
2023-10
Author(s)
Hama, Natsumi
Sunaga, Yuma
Ochiai, Hirotaka
Kokaze, Akatsuki
Watanabe, Hideaki
Kurosawa, Michiko
Azukizawa, Hiroaki
Asada, Hideo
Watanabe, Yuko
Yamaguchi, Yukie
Aihara, Michiko
Mizukawa, Yoshiko
Ohyama, Manabu
Hashizume, Hideo
Nakajima, Saeko
Nomura, Takashi
Kabashima, Kenji
Tohyama, Mikiko
Hasegawa, Akito
Takahashi, Hayato
Mieno, Hiroki
Ueta, Mayumi
Sotozono, Chie
Niihara, Hiroyuki
Morita, Eishin
Brüggen, Marie-Charlotte
Feingold, Iris Motro
Jeschke, Marc G
Dodiuk-Gad, Roni P
Oppel, Eva Maria
French, Lars E
Chen, Wei-Ti
Chung, Wen-Hung
Kang, Hye-Ryun
Ingen-Housz-Oro, Saskia
Nakamura, Kazutoshi
Sueki, Hirohiko
Abe, Riichiro
Abstract
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening, severe mucocutaneous adverse reactions. Severity prediction at early onset is urgently required for treatment. However, previous prediction scores have been based on data of blood tests.
Subjects
Disease mortality
Scoring system
Stevens-Johnson syndrome
Toxic epidermal necrolysis
SDGs
Type
journal article